ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,383,000 | +90.0% | 94,600 | 0.0% | 0.05% | +88.0% |
| Q1 2019 | $2,307,000 | +3343.3% | 94,600 | +1935.3% | 0.02% | +2400.0% |
| Q4 2018 | $67,000 | -5.6% | 4,648 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $71,000 | -7.8% | 4,648 | +1.0% | 0.00% | 0.0% |
| Q2 2018 | $77,000 | +2.7% | 4,600 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $75,000 | -44.0% | 4,600 | -56.2% | 0.00% | 0.0% |
| Q4 2017 | $134,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |